Shell Asset Management Co. decreased its stake in ICU Medical Inc. (NASDAQ:ICUI) by 5.4% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 3,345 shares of the company’s stock after selling 190 shares during the period. Shell Asset Management Co.’s holdings in ICU Medical were worth $377,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Virginia Retirement System purchased a new stake in ICU Medical during the first quarter valued at $333,000. Teachers Advisors Inc. boosted its stake in ICU Medical by 13.3% in the first quarter. Teachers Advisors Inc. now owns 202,753 shares of the company’s stock valued at $21,107,000 after buying an additional 23,812 shares during the period. JPMorgan Chase & Co. boosted its stake in ICU Medical by 63.5% in the first quarter. JPMorgan Chase & Co. now owns 185,078 shares of the company’s stock valued at $19,267,000 after buying an additional 71,891 shares during the period. Menta Capital LLC boosted its stake in ICU Medical by 157.1% in the first quarter. Menta Capital LLC now owns 5,400 shares of the company’s stock valued at $562,000 after buying an additional 3,300 shares during the period. Finally, M&T Bank Corp boosted its stake in ICU Medical by 3.3% in the first quarter. M&T Bank Corp now owns 2,117 shares of the company’s stock valued at $220,000 after buying an additional 67 shares during the period. Institutional investors own 89.52% of the company’s stock.
ICU Medical Inc. (NASDAQ:ICUI) traded down 0.81% on Tuesday, hitting $148.75. 205,106 shares of the company’s stock were exchanged. ICU Medical Inc. has a 52-week low of $85.56 and a 52-week high of $152.67. The stock has a market cap of $2.40 billion, a P/E ratio of 44.30 and a beta of 0.37. The firm has a 50 day moving average price of $126.86 and a 200-day moving average price of $113.00.
ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Monday, August 8th. The company reported $1.15 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.05 by $0.10. The firm earned $96.70 million during the quarter, compared to analyst estimates of $89.66 million. ICU Medical had a net margin of 14.94% and a return on equity of 10.33%. The business’s quarterly revenue was up 15.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.97 EPS. Analysts predict that ICU Medical Inc. will post $4.54 earnings per share for the current fiscal year.
A number of research firms have commented on ICUI. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $140.00 price target for the company in a report on Friday, August 12th. Piper Jaffray Cos. restated a “neutral” rating and issued a $119.00 price target (up from $115.00) on shares of ICU Medical in a report on Thursday, August 11th.
In other news, VP Steven Riggs sold 44,739 shares of the business’s stock in a transaction that occurred on Tuesday, September 13th. The shares were sold at an average price of $121.78, for a total value of $5,448,315.42. Following the completion of the sale, the vice president now directly owns 675 shares in the company, valued at approximately $82,201.50. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Scott E. Lamb sold 1,474 shares of the business’s stock in a transaction that occurred on Tuesday, September 13th. The stock was sold at an average price of $121.61, for a total transaction of $179,253.14. Following the completion of the sale, the chief financial officer now owns 4,705 shares of the company’s stock, valued at $572,175.05. The disclosure for this sale can be found here. 15.90% of the stock is currently owned by insiders.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical Inc. (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.